# A Closer Look: The Expanded Endocannabinoid System

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/deep-dive-the-expanded-endocannabinoid-system/
> **Published:** 2025-01-18T01:39:35-04:00 | **Last Modified / Clinically Audited:** 2026-09-27T23:33:18-04:00
> **Clinical Summary:** Science &amp; Research · The Endocannabinoid System Beyond CB1 &amp; CB2: How Cannabis Affects More Than You Think Medically reviewed by Dr. Benjamin Caplan, MD · Last updated August 3, 2026 Most people think of cannabis as working through just two receptors, CB1 and CB2, but that’s only part of the story. Cannabis interacts with [&hellip;]

---

Science & Research · The [Endocannabinoid System](https://cedclinic.com/endocannabinoid-system-fear-extinction/)

## Beyond CB1 & CB2: How Cannabis Affects More Than You Think

Medically reviewed by [Dr. Benjamin Caplan](/drcaplan/), MD · Last updated August 3, 2026

Most people think of cannabis as working through just two receptors, CB1 and CB2, but that’s only part of the story. Cannabis interacts with a wide network of biological systems, from mood and pain to metabolism, inflammation, and even bone health, influencing serotonin, dopamine, opioid, TRP, PPAR, and GPR pathways, plus enzymes like FAAH and MAGL that regulate your body’s own endocannabinoids. This expanded view of the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) (ECS) helps explain why cannabis can be so effective for such a broad range of conditions, and why personalized, evidence-based guidance matters more than ever.

[The Quick Version](#basics)[The Receptor Systems](#systems)[Why This Matters](#bigger-picture)[Next Steps](#next-steps)

## The Quick Version: Four Systems Beyond CB1 & CB2

You may have heard of CB1 and [CB2 receptors](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/), but the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) is much more complex. Cannabis influences many other receptors, enzymes, and pathways, each contributing to different therapeutic effects.

### TRPV1 (Vanilloid Receptors)

Involved in pain perception, inflammation, and body temperature regulation, also activated by spicy foods like chili peppers.

### PPARs

Involved in metabolism, immune function, and neuroprotection, relevant to neurodegenerative disease research.

### GPR55

Sometimes called the “third cannabinoid receptor,” involved in bone health, cancer progression, and inflammation regulation.

### FAAH & MAGL Enzymes

Break down natural endocannabinoids like anandamide. By slowing this breakdown, cannabis can enhance mood stabilization, pain relief, and stress reduction.

 Why this matters: understanding these additional pathways helps explain why cannabis works for such a wide variety of conditions, from chronic pain and anxiety to neurodegenerative disease and metabolic disorders. [Schedule a consultation to discuss your unique physiology →](/book/)

## The Receptor Systems, One by One

Cannabis does far more than activate CB1 (brain) and CB2 (immune system) receptors. Here is a deeper look at the other key players in the endocannabinoid system and beyond.

### Dopamine, Serotonin & Opioid Receptors: The Brain’s Reward & Mood Regulators

Cannabinoids influence the same neurotransmitter systems that antidepressants, opioids, and stimulants target. Dopamine receptors (D1 to D5) can be increased or modulated by cannabis, influencing motivation and reward-seeking behavior; serotonin receptors (5-HT1A, 5-HT2A) are where CBD interacts to reduce anxiety and depression; and opioid receptors (μ, κ, δ) are affected by cannabinoids in ways that enhance pain relief and reduce opioid withdrawal symptoms.

 Why it matters: this explains why cannabis can reduce anxiety, depression, and pain while also offering potential in [addiction treatment](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/). 

### The TRP Family: Pain, Inflammation & Sensory Perception

Cannabis doesn’t just numb pain, it actively changes how pain is processed. TRPV1, the “capsaicin receptor,” helps regulate pain perception, inflammation, and body temperature, and is activated by both cannabis and spicy foods. TRPV2 and TRPV4 are involved in neuropathic pain, heat sensitivity, and inflammatory response. TRPA1, the “wasabi receptor,” affects pain sensation, gut inflammation, and respiratory conditions like asthma.

 Why it matters: this explains why cannabis helps with nerve pain, migraines, muscle spasms, and inflammatory pain syndromes. 

### The PPAR System: Metabolism, Inflammation & Neuroprotection

PPARs (peroxisome proliferator-activated receptors) regulate fat metabolism, immune function, and brain cell survival. PPAR-α and PPAR-γ are found in liver, fat cells, and brain tissue, affecting blood sugar control, inflammation, and neurodegeneration. PPAR activation by cannabinoids may explain cannabis’s potential benefits in diabetes, Alzheimer’s, and autoimmune conditions.

 Why it matters: this highlights cannabis’s potential role in neurodegenerative disease, metabolic disorders, and chronic inflammation. 

### GPR Receptors: The “Forgotten” Cannabinoid Targets

GPR receptors (G protein-coupled receptors) are involved in immune response, bone growth, and metabolic regulation. GPR18 regulates immune response and inflammation, with potential relevance to autoimmune diseases like multiple sclerosis. GPR55, sometimes called the “CB3 receptor,” affects bone health, cancer growth, and gut function. GPR119 is involved in insulin secretion and appetite regulation, relevant to diabetes and obesity research.

 Why it matters: GPR receptors expand cannabis’s role beyond pain relief into immune function, metabolic balance, and bone health. 

### The Endothelial System: Cardiovascular Health

Cannabis affects blood flow, vascular inflammation, and heart rate through its interactions with endothelial cells and vascular receptors. CBD may lower blood pressure by dilating blood vessels, cannabis can reduce inflammation in arterial walls, and THC and CBD interact with nitric oxide pathways that regulate blood vessel function.

 Why it matters: cannabis’s cardiovascular effects are complex, some people may benefit from its anti-inflammatory properties, while others may experience an increase in heart rate. Discuss cardiovascular history with your provider. 

### FAAH & MAGL: Extending the Life of Your Natural Endocannabinoids

Your body produces its own cannabinoids, anandamide (the “bliss molecule”) and 2-AG,but enzymes break them down quickly. FAAH (fatty acid amide hydrolase) breaks down anandamide, reducing its natural calming effects; CBD inhibits FAAH, allowing anandamide levels to stay higher for longer. MAGL (monoacylglycerol lipase) degrades 2-AG, which influences pain, inflammation, and brain plasticity.

 Why it matters: this helps explain why CBD is non-intoxicating yet still enhances mood, reduces anxiety, and eases pain. 

## The Bigger Picture: Why This Matters for Medical Cannabis

Understanding cannabis beyond CB1 and CB2 helps explain three things patients ask about most often.

Why cannabis works for such a wide range of conditions: pain, inflammation, metabolism, mood disorders, neurodegenerative disease, and more.

Why different [cannabinoids and terpenes](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) matter: each activates different receptor systems.

Why cannabis affects people differently: genetics, metabolism, and existing conditions all play a role.

Takeaway: cannabis is far more than a simple “CB1/CB2 activator.” Its effects extend across multiple biological systems, influencing health and disease in ways modern medicine is only beginning to understand.

## Next Steps: Your Cannabis Journey Begins Here

Now that you understand the basics, here’s what comes next.

1

[Check if you qualify](/overview-of-qualifying-conditions/) for medical cannabis if you’re experiencing chronic pain, anxiety, sleep disturbances, or other health challenges.

2

[Book a consultation](/book/) with a licensed provider to discuss whether cannabis is right for you.

3

[Register for the Massachusetts Medical Use of Marijuana Program](https://patient.massciportal.com/mmj-patient/login) and get your medical cannabis card.

4

[Visit a licensed dispensary](/resources/massachusetts-dispensary-map/) and choose the best products for your needs.

## Ready to Take Control of Your Health?

For a comprehensive, evidence-based guide to using cannabis effectively, check out *The [Doctor-Approved Cannabis](https://cedclinic.com/doctor-approved-cannabis-handbook-endorsements/) Handbook*, your go-to resource for science-backed insights and practical strategies. Or schedule personalized guidance directly with Dr. Caplan.

[Book Your Consultation](/book/)[Read the Handbook](https://amzn.to/4a35lhE)

Questions? See our [FAQ](/faq/) or [email CED Clinic](mailto:Questions@CEDclinic.com). Explore our [cannabis science library](/resources/cannabis-literature-library/).

[https://amzn.to/4a35lhE](https://amzn.to/4a35lhE)

## Gallery

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
